Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

A Prognostic Tool for Individualized Prediction of Graft Failure Risk within Ten Years after Kidney Transplantation.

Tytuł:
A Prognostic Tool for Individualized Prediction of Graft Failure Risk within Ten Years after Kidney Transplantation.
Autorzy:
Stamenic D; INSERM, U1248, F-87000 Limoges, France.; University of Limoges, UMR_1248, F-87000 Limoges, France.
Rousseau A; INSERM, U1248, F-87000 Limoges, France.; University of Limoges, UMR_1248, F-87000 Limoges, France.
Essig M; INSERM, U1248, F-87000 Limoges, France.; University of Limoges, UMR_1248, F-87000 Limoges, France.
Gatault P; CHU Tours, Service Néphrologie et Immunologie Clinique, F-37000 Tours, France.
Buchler M; CHU Tours, Service Néphrologie et Immunologie Clinique, F-37000 Tours, France.
Filloux M; CHU Limoges, Service d'immunologie et immunogénétique, F-87000 Limoges, France.; CNRS, CRIBL, UMR 7276, F-87000 Limoges, France.
Marquet P; INSERM, U1248, F-87000 Limoges, France.; University of Limoges, UMR_1248, F-87000 Limoges, France.; CHU Limoges, Service de Pharmacologie, Toxicologie, et Pharmacovigilance, F-87000 Limoges, France.
Prémaud A; INSERM, U1248, F-87000 Limoges, France.; University of Limoges, UMR_1248, F-87000 Limoges, France.
Źródło:
Journal of transplantation [J Transplant] 2019 Apr 08; Vol. 2019, pp. 7245142. Date of Electronic Publication: 2019 Apr 08 (Print Publication: 2019).
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: [New York, NY] : Hindawi Pub. Corp.
References:
Am J Kidney Dis. 2002 Apr;39(4):762-8. (PMID: 11920342)
Am J Transplant. 2003 Jun;3(6):715-21. (PMID: 12780563)
J Am Soc Nephrol. 2003 Nov;14(11):2967-74. (PMID: 14569108)
J Am Soc Nephrol. 2005 Sep;16(9):2804-12. (PMID: 16014742)
Biostatistics. 2009 Jul;10(3):535-49. (PMID: 19369642)
Transplantation. 2009 Jul 27;88(2):231-6. (PMID: 19623019)
Kidney Int. 2010 Dec;78(12):1288-94. (PMID: 20861817)
Am J Transplant. 2011 Mar;11(3):450-62. (PMID: 20973913)
Transplantation. 2011 May 27;91(10):1103-9. (PMID: 21403588)
Stat Methods Med Res. 2014 Feb;23(1):74-90. (PMID: 22517270)
Lancet. 2013 Jan 26;381(9863):313-9. (PMID: 23182298)
Am J Nephrol. 2012;36(6):561-9. (PMID: 23221105)
Transplantation. 2013 Feb 15;95(3):410-7. (PMID: 23380861)
Pharmacol Res. 2013 Jun;72:52-60. (PMID: 23557931)
Transplantation. 2013 Nov 27;96(10):919-25. (PMID: 23912173)
Am J Kidney Dis. 2014 Apr;63(4):643-51. (PMID: 24387794)
Stat Methods Med Res. 2016 Dec;25(6):2972-2991. (PMID: 24847900)
Kidney Int. 2015 Feb;87(2):343-9. (PMID: 25229341)
Int J Epidemiol. 2015 Feb;44(1):334-44. (PMID: 25604450)
BMJ. 2015 Jul 31;351:h3557. (PMID: 26232393)
J Am Soc Nephrol. 2016 Jan;27(1):293-304. (PMID: 26293822)
Stat Med. 2016 Feb 10;35(3):382-98. (PMID: 26376900)
Eur J Epidemiol. 2016 May;31(5):469-79. (PMID: 26832337)
J Am Soc Nephrol. 2016 Oct;27(10):3165-3174. (PMID: 26961348)
Clin Transplant. 2016 Sep;30(9):1108-14. (PMID: 27327607)
J Am Soc Nephrol. 2017 Feb;28(2):702-715. (PMID: 27493255)
Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii185-ii193. (PMID: 28031345)
J Immunol Res. 2017;2017:5201098. (PMID: 28133619)
J Am Soc Nephrol. 2017 Oct;28(10):3014-3023. (PMID: 28592422)
PLoS One. 2017 Jul 3;12(7):e0180236. (PMID: 28671951)
Hum Immunol. 2017 Sep;78(9):526-533. (PMID: 28732720)
J Am Soc Nephrol. 2018 Feb;29(2):606-619. (PMID: 29255058)
Entry Date(s):
Date Created: 20190517 Latest Revision: 20201001
Update Code:
20240104
PubMed Central ID:
PMC6476124
DOI:
10.1155/2019/7245142
PMID:
31093367
Czasopismo naukowe
Identification of patients at risk of kidney graft loss relies on early individual prediction of graft failure. Data from 616 kidney transplant recipients with a follow-up of at least one year were retrospectively studied. A joint latent class model investigating the impact of serum creatinine (Scr) time-trajectories and onset of de novo donor-specific anti-HLA antibody ( dn DSA) on graft survival was developed. The capacity of the model to calculate individual predicted probabilities of graft failure over time was evaluated in 80 independent patients. The model classified the patients in three latent classes with significantly different Scr time profiles and different graft survivals. Donor age contributed to explaining latent class membership. In addition to the SCr classes, the other variables retained in the survival model were proteinuria measured one-year after transplantation (HR=2.4, p=0.01), pretransplant non-donor-specific antibodies (HR=3.3, p<0.001), and dn DSA in patient who experienced acute rejection (HR=15.9, p=0.02). In the validation dataset, individual predictions of graft failure risk provided good predictive performances (sensitivity, specificity, and overall accuracy of graft failure prediction at ten years were 77.7%, 95.8%, and 85%, resp.) for the 60 patients who had not developed dn DSA. For patients with dn DSA individual risk of graft failure was not predicted with a so good performance.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies